6 things we learned from the Covid-19 vaccine report

by



[ad_1]

From acknowledging that NPHET’s message is not always what people want to hear, to confirming that Ireland will not get out of the European Medicines Agency process to approve Sputnik or any other vaccine, here are six things we learned in tonight’s briefing.

NPHET recognizes that the message is not always popular

In response to the reaction to comments made at yesterday’s NPHET briefing about the possibility of the restrictions being extended through June, Deputy Medical Director Dr. Ronan Glynn said he understands that people are fatigued with the restrictions. .

He asked people to view the comments in the context of the entire briefing, which he said recognizes the enormous sacrifices people have made, and said the vast majority of people are following the guidelines.

However, he said, sadly, the things we need to do to control the spread of the virus have not changed.

He said NPHET officials are not media experts and their message can always be improved. But finally, he said that the key advice has not changed.

No concern about clotting reports in Ireland

Dr Donal O’Connor said at the briefing that there have been some reports of clotting in Ireland after people have been vaccinated, but that the numbers are low and follow the typical pattern where risk factors already exist.

He said he is surprised that the number of reports is not greater and that there is no concern that the frequency is higher than would be expected regardless of vaccines.

The implementation pause meant a slight postponement

CANI President Professor Karina Butler said stopping the launch of the AstraZeneca vaccine was the right thing to do while they reviewed reports of side effects.

He said that did not mean that the 30,000 people who were scheduled to receive the vaccine this week would not receive the vaccine, only that their vaccinations would be delayed a bit pending the review.

Hesitation before the vaccine

On concerns that the decision by Irish authorities and other governments in Europe to suspend use of the vaccine could undermine public confidence, Dr. Glynn said that was cause for concern, but expressed hope that the same would happen. contrary.

He said he hoped people would see the benefits of taking a cautious approach and feel reassured that officials are being extremely vigilant in responding to any security concerns.

Ireland will follow the EMA process for all vaccines

When asked if Ireland would consider making its own decision on the Russian-developed Sputnik vaccine to address the shortage of doses available here, Dr Glynn said that Ireland will never get out of the European Medicines Agency process.

The Russian-made vaccine is being continuously reviewed by the EMA, the briefing was said.

People are urged to take the vaccines offered

On the idea that an alternative could be offered to people who might refuse to take the AstraZeneca vaccine, Professor Butler said that all the vaccines that are arriving in the country are given almost as soon as they arrive, and that there are no more. vaccines available.

He said that there are three vaccines approved in Ireland at the moment, and they are all safe and very effective.

Dr. Glynn also urged people to take the AstraZeneca vaccine if it was offered, saying, “It is a safe vaccine, it is an effective vaccine. We can see the effectiveness in case loads in other jurisdictions. We are lucky to have it.”



[ad_2]